GT Biopharma, Inc. (GTBP) — research page
US · us-cm-kg/NASDAQ/GTBP · as of 2026-11-08
Identity and listing
The issuer is GT Biopharma, Inc., listed on NASDAQ under the ticker GTBP. The ISIN is not on the record and the LEI is not on the record. The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is the United States, Delaware. The segment is not on the record. The listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | GT Biopharma, Inc. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | GTBP | source · 2026-11-08 |
| ISIN | not on the record | |
| LEI | not on the record | |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2834 Pharmaceutical Preparations | source · 2026-11-08 |
| jurisdiction | United States — Delaware | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 40 filings across 30 filing days in the window 2025-11-08 to 2026-11-08. Of these, 11 are regulatory filings, 8 are prospectuses, 7 are results, 5 are AGM or EGM filings, 5 are corporate news, 2 are ad hoc, and 2 are halt or suspension filings. The median gap between filing days is 6 days. The latest filing is dated 2026-10-20 and is of type regulatory_filing, 19 days before the record date. On NASDAQ the median filings are 52, the median cadence gap is 6.0 days, and the median latency is 5.0 days. On the sector 2834 Pharmaceutical Preparations the median filings are 63.0, the median cadence gap is 6.0 days, and the median latency is 4.0 days.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 40 | 6 | 19 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2834 Pharmaceutical Preparations (526 issuers) | 63 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-20 | regulatory_filing | EFFECT | EFFECT (items ,,) |
| 2026-10-20 | prospectus | 424B3 | 424B3 — 424B3 |
| 2026-10-13 | agm_egm | DEF 14A | DEF 14A — DEF 14A |
| 2026-10-09 | prospectus | S-1 | S-1 — S-1 |
| 2026-10-02 | agm_egm | PRE 14A | PRE 14A — PRE 14A |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is Weinberg & Company, P.A., located in Los Angeles, California. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.
Orderability
The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
One research house is named on the issuer's own investor-relations page: Roth Capital Partners.
| research house | analyst | source · read date |
|---|---|---|
| Roth Capital Partners | Jonathan Aschoff, Ph.D. | issuer page · 2026-11-11 |
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for the issuer. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12.
Sources
8 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://data.sec.gov/submissions/CIK0000109657.json (identity.jurisdiction)
- 10.3
- https://mcp.us-cm-kg.ai/events/NASDAQ/GTBP (the disclosure lines)
- 10.4
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.5
- https://www.sec.gov/Archives/edgar/data/109657/000149315226008443/form10-k.htm (the auditor)
- 10.6
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.7
- https://ir.gtbiopharma.com/analyst-coverage (coverage)
- 10.8
- https://mcp.us-cm-kg.ai/record/NASDAQ/GTBP (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"ticker":"GTBP","exchange":"NASDAQ"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:073e57b10525d790.